No Data
No Data
Bausch Health: U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, Teva Against Norwich
Trump Targets Medicare Price Negotiations in New Executive Order
Options Market Statistics: Ford Stock Rises Despite S&P Downgrade Warning; Options Pop
Unusual Options Activity: TEVA, DAL and Others Attract Market Bets, TEVA V/OI Ratio Reaches 188.8
Teva Pharmaceutical Industries Options Spot-On: On April 14th, 92,555 Contracts Were Traded, With 845.15K Open Interest
Research Alert: CFRA Cuts Opinion On Shares Of Teva Pharmaceutical Industries To Sell From Hold